Unbalanced Placental Expression of Imprinted Genes in Human Intrauterine Growth Restriction

J. McMinn, M. Wei, N. Schupf, J. Cusmai, E. B. Johnson, A. C. Smith, R. Weksberg, Harshwardhan Thaker, B. Tycko

Research output: Contribution to journalArticle

207 Citations (Scopus)

Abstract

Imprinted genes control fetal and placental growth in mice and in rare human syndromes, but the role of these genes in sporadic intrauterine growth restriction (IUGR) is less well-studied. We measured the ratio of mRNA from a maternally expressed imprinted gene, PHLDA2, to that from a paternally expressed imprinted gene, MEST, by Northern blotting in 38 IUGR-associated placentae and 75 non-IUGR placentae and found an increase in the PHLDA2/MEST mRNA ratio in IUGR (p = 0.0001). Altered expression of PHLDA2 and MEST was not accompanied by changes in DNA methylation within their imprinting centers, and immunohistochemistry showed PHLDA2 protein appropriately restricted to villous and intermediate cytotrophoblast in the IUGR placentae. We next did a genome-wide survey of mRNA expression in 14 IUGR placentae with maternal vascular under-perfusion compared to 15 non-IUGR placentae using Affymetrix U133A microarrays. In this series six imprinted genes were differentially expressed by ANOVA with a Benjamini-Hochberg false discovery rate of 0.05, with increased expression of PHLDA2 and decreased expression of MEST, MEG3, GATM, GNAS and PLAGL1 in IUGR placentae. At lower significance, we found IGF2 mRNA decreased and CDKN1C mRNA increased in the IUGR cases. We confirmed the significant reduction in MEG3 non-translated RNA in IUGR placentae by Northern blotting. In addition to imprinted genes, the microarray data highlighted non-imprinted genes acting in endocrine signaling (LEP, CRH, HPGD, INHBA), tissue growth (IGF1), immune modulation (INDO, PSG-family genes), oxidative metabolism (GLRX), vascular function (AGTR1, DSCR1) and metabolite transport (SLC-family solute carriers) as differentially expressed in IUGR vs. non-IUGR placentae.

Original languageEnglish (US)
Pages (from-to)540-549
Number of pages10
JournalPlacenta
Volume27
Issue number6-7
DOIs
StatePublished - Jun 1 2006
Externally publishedYes

Fingerprint

Gene Expression
Placenta
Growth
Genes
Messenger RNA
Northern Blotting
Blood Vessels
Trophoblasts
DNA Methylation
Fetal Development
Analysis of Variance
Perfusion
Immunohistochemistry
Mothers
Genome
RNA

Keywords

  • Imprinting
  • Intrauterine growth restriction
  • IUGR
  • MEG3
  • MEST
  • PHLDA2
  • Placenta

ASJC Scopus subject areas

  • Reproductive Medicine
  • Obstetrics and Gynecology
  • Developmental Biology

Cite this

McMinn, J., Wei, M., Schupf, N., Cusmai, J., Johnson, E. B., Smith, A. C., ... Tycko, B. (2006). Unbalanced Placental Expression of Imprinted Genes in Human Intrauterine Growth Restriction. Placenta, 27(6-7), 540-549. https://doi.org/10.1016/j.placenta.2005.07.004

Unbalanced Placental Expression of Imprinted Genes in Human Intrauterine Growth Restriction. / McMinn, J.; Wei, M.; Schupf, N.; Cusmai, J.; Johnson, E. B.; Smith, A. C.; Weksberg, R.; Thaker, Harshwardhan; Tycko, B.

In: Placenta, Vol. 27, No. 6-7, 01.06.2006, p. 540-549.

Research output: Contribution to journalArticle

McMinn, J, Wei, M, Schupf, N, Cusmai, J, Johnson, EB, Smith, AC, Weksberg, R, Thaker, H & Tycko, B 2006, 'Unbalanced Placental Expression of Imprinted Genes in Human Intrauterine Growth Restriction', Placenta, vol. 27, no. 6-7, pp. 540-549. https://doi.org/10.1016/j.placenta.2005.07.004
McMinn J, Wei M, Schupf N, Cusmai J, Johnson EB, Smith AC et al. Unbalanced Placental Expression of Imprinted Genes in Human Intrauterine Growth Restriction. Placenta. 2006 Jun 1;27(6-7):540-549. https://doi.org/10.1016/j.placenta.2005.07.004
McMinn, J. ; Wei, M. ; Schupf, N. ; Cusmai, J. ; Johnson, E. B. ; Smith, A. C. ; Weksberg, R. ; Thaker, Harshwardhan ; Tycko, B. / Unbalanced Placental Expression of Imprinted Genes in Human Intrauterine Growth Restriction. In: Placenta. 2006 ; Vol. 27, No. 6-7. pp. 540-549.
@article{e4f4a6aa1919482594da08afb24e0646,
title = "Unbalanced Placental Expression of Imprinted Genes in Human Intrauterine Growth Restriction",
abstract = "Imprinted genes control fetal and placental growth in mice and in rare human syndromes, but the role of these genes in sporadic intrauterine growth restriction (IUGR) is less well-studied. We measured the ratio of mRNA from a maternally expressed imprinted gene, PHLDA2, to that from a paternally expressed imprinted gene, MEST, by Northern blotting in 38 IUGR-associated placentae and 75 non-IUGR placentae and found an increase in the PHLDA2/MEST mRNA ratio in IUGR (p = 0.0001). Altered expression of PHLDA2 and MEST was not accompanied by changes in DNA methylation within their imprinting centers, and immunohistochemistry showed PHLDA2 protein appropriately restricted to villous and intermediate cytotrophoblast in the IUGR placentae. We next did a genome-wide survey of mRNA expression in 14 IUGR placentae with maternal vascular under-perfusion compared to 15 non-IUGR placentae using Affymetrix U133A microarrays. In this series six imprinted genes were differentially expressed by ANOVA with a Benjamini-Hochberg false discovery rate of 0.05, with increased expression of PHLDA2 and decreased expression of MEST, MEG3, GATM, GNAS and PLAGL1 in IUGR placentae. At lower significance, we found IGF2 mRNA decreased and CDKN1C mRNA increased in the IUGR cases. We confirmed the significant reduction in MEG3 non-translated RNA in IUGR placentae by Northern blotting. In addition to imprinted genes, the microarray data highlighted non-imprinted genes acting in endocrine signaling (LEP, CRH, HPGD, INHBA), tissue growth (IGF1), immune modulation (INDO, PSG-family genes), oxidative metabolism (GLRX), vascular function (AGTR1, DSCR1) and metabolite transport (SLC-family solute carriers) as differentially expressed in IUGR vs. non-IUGR placentae.",
keywords = "Imprinting, Intrauterine growth restriction, IUGR, MEG3, MEST, PHLDA2, Placenta",
author = "J. McMinn and M. Wei and N. Schupf and J. Cusmai and Johnson, {E. B.} and Smith, {A. C.} and R. Weksberg and Harshwardhan Thaker and B. Tycko",
year = "2006",
month = "6",
day = "1",
doi = "10.1016/j.placenta.2005.07.004",
language = "English (US)",
volume = "27",
pages = "540--549",
journal = "Placenta",
issn = "0143-4004",
publisher = "W.B. Saunders Ltd",
number = "6-7",

}

TY - JOUR

T1 - Unbalanced Placental Expression of Imprinted Genes in Human Intrauterine Growth Restriction

AU - McMinn, J.

AU - Wei, M.

AU - Schupf, N.

AU - Cusmai, J.

AU - Johnson, E. B.

AU - Smith, A. C.

AU - Weksberg, R.

AU - Thaker, Harshwardhan

AU - Tycko, B.

PY - 2006/6/1

Y1 - 2006/6/1

N2 - Imprinted genes control fetal and placental growth in mice and in rare human syndromes, but the role of these genes in sporadic intrauterine growth restriction (IUGR) is less well-studied. We measured the ratio of mRNA from a maternally expressed imprinted gene, PHLDA2, to that from a paternally expressed imprinted gene, MEST, by Northern blotting in 38 IUGR-associated placentae and 75 non-IUGR placentae and found an increase in the PHLDA2/MEST mRNA ratio in IUGR (p = 0.0001). Altered expression of PHLDA2 and MEST was not accompanied by changes in DNA methylation within their imprinting centers, and immunohistochemistry showed PHLDA2 protein appropriately restricted to villous and intermediate cytotrophoblast in the IUGR placentae. We next did a genome-wide survey of mRNA expression in 14 IUGR placentae with maternal vascular under-perfusion compared to 15 non-IUGR placentae using Affymetrix U133A microarrays. In this series six imprinted genes were differentially expressed by ANOVA with a Benjamini-Hochberg false discovery rate of 0.05, with increased expression of PHLDA2 and decreased expression of MEST, MEG3, GATM, GNAS and PLAGL1 in IUGR placentae. At lower significance, we found IGF2 mRNA decreased and CDKN1C mRNA increased in the IUGR cases. We confirmed the significant reduction in MEG3 non-translated RNA in IUGR placentae by Northern blotting. In addition to imprinted genes, the microarray data highlighted non-imprinted genes acting in endocrine signaling (LEP, CRH, HPGD, INHBA), tissue growth (IGF1), immune modulation (INDO, PSG-family genes), oxidative metabolism (GLRX), vascular function (AGTR1, DSCR1) and metabolite transport (SLC-family solute carriers) as differentially expressed in IUGR vs. non-IUGR placentae.

AB - Imprinted genes control fetal and placental growth in mice and in rare human syndromes, but the role of these genes in sporadic intrauterine growth restriction (IUGR) is less well-studied. We measured the ratio of mRNA from a maternally expressed imprinted gene, PHLDA2, to that from a paternally expressed imprinted gene, MEST, by Northern blotting in 38 IUGR-associated placentae and 75 non-IUGR placentae and found an increase in the PHLDA2/MEST mRNA ratio in IUGR (p = 0.0001). Altered expression of PHLDA2 and MEST was not accompanied by changes in DNA methylation within their imprinting centers, and immunohistochemistry showed PHLDA2 protein appropriately restricted to villous and intermediate cytotrophoblast in the IUGR placentae. We next did a genome-wide survey of mRNA expression in 14 IUGR placentae with maternal vascular under-perfusion compared to 15 non-IUGR placentae using Affymetrix U133A microarrays. In this series six imprinted genes were differentially expressed by ANOVA with a Benjamini-Hochberg false discovery rate of 0.05, with increased expression of PHLDA2 and decreased expression of MEST, MEG3, GATM, GNAS and PLAGL1 in IUGR placentae. At lower significance, we found IGF2 mRNA decreased and CDKN1C mRNA increased in the IUGR cases. We confirmed the significant reduction in MEG3 non-translated RNA in IUGR placentae by Northern blotting. In addition to imprinted genes, the microarray data highlighted non-imprinted genes acting in endocrine signaling (LEP, CRH, HPGD, INHBA), tissue growth (IGF1), immune modulation (INDO, PSG-family genes), oxidative metabolism (GLRX), vascular function (AGTR1, DSCR1) and metabolite transport (SLC-family solute carriers) as differentially expressed in IUGR vs. non-IUGR placentae.

KW - Imprinting

KW - Intrauterine growth restriction

KW - IUGR

KW - MEG3

KW - MEST

KW - PHLDA2

KW - Placenta

UR - http://www.scopus.com/inward/record.url?scp=33645902182&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=33645902182&partnerID=8YFLogxK

U2 - 10.1016/j.placenta.2005.07.004

DO - 10.1016/j.placenta.2005.07.004

M3 - Article

C2 - 16125225

AN - SCOPUS:33645902182

VL - 27

SP - 540

EP - 549

JO - Placenta

JF - Placenta

SN - 0143-4004

IS - 6-7

ER -